Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BGM0504 in Type 2 Diabetes Mellitus – Phase II
CTR20232464Phase 2Completed
- Sponsor
- Borray New Creation Biopharmaceutical Technology
- Start
- Aug 2023
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of BGM0504 in type 2 diabetes mellitus (T2DM), sponsored by Borray New Creation Biopharmaceutical Technology. Started Aug 2023; status: completed.
02
Drugs
BGM0504
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on CTR20232464.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20232464.